Lipisafe 40mg Tablet contains Atorvastatin 40mg, a potent lipid-lowering agent belonging to the statin class, primarily indicated for the management of hypercholesterolemia and prevention of cardiovascular disease. Atorvastatin functions by selectively inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, thereby reducing total cholesterol, low-density lipoprotein cholesterol (LDL-C), and triglycerides, while modestly increasing high-density lipoprotein cholesterol (HDL-C). Lipisafe 40mg is prescribed as part of a comprehensive treatment plan including diet, exercise, and lifestyle modifications to reduce the risk of atherosclerosis, myocardial infarction, stroke, and other cardiovascular events in patients with elevated cholesterol levels or established coronary heart disease. The tablet is indicated for primary and secondary prevention of cardiovascular disease in adults at high risk and for familial hypercholesterolemia. Dosage should be individualized based on therapeutic response and tolerability, with regular monitoring of lipid profiles and liver function tests recommended. Common adverse effects include headache, myalgia, and gastrointestinal disturbances; rare but serious risks involve myopathy and hepatotoxicity. Lipisafe 40mg should be used cautiously in patients with hepatic impairment or a history of muscle disorders and is contraindicated during pregnancy and lactation.